sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Adult Hemoglobinopathy Testing

Adult Hemoglobinopathy Testing Market By Variant Type (Variant A2, and Variant F), By Test Type (HPLC Test, Mass Spectrometry, and Hemoglobin Electrophoresis), End User (Hospitals, Reference Laboratories, and Academic & Medical Institutes): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026

  • Publish On: Jul-2021
  • Total Pages: 197
  • Report Code: FAF-1564
  • Base Year: 2020
  • Format:

Industry Insights

[197+ Pages Report] Over the projected period, the adult hemoglobinopathy testing market is projected to develop rapidly. The global adult hemoglobinopathy testing market was worth USD 330 Million in 2020 and is expected to be worth about USD 430 Million by 2026, expanding at a CAGR of 3.9%.

Global Adult Hemoglobinopathy Testing Market: Overview

Hemoglobinopathy is caused by genetic abnormalities and anemia. Structure defects in the hemoglobin molecule decreased synthesis of one of the two subunits of the hemoglobin molecule, and pathological interactions of normally usual subunits both contribute to the development of irregular hemoglobin. There are two types of disorders: extreme and moderate. The hemoglobin (Hb) molecule is either decreased in development or has its structure altered as a result of these mutations. The existence of variant hemoglobin in red blood cells causes hemoglobinopathy disease. The global adult hemoglobinopathy testing market is expected to grow at a rapid pace as a result of a number of government-provided health services, such as payment programs for therapies and diagnostic tests, as well as the care of current hemoglobinopathy patients. NGO's are now working hard to develop advanced research techniques for hemoglobinopathy diagnosis. Global adult hemoglobinopathy is also on the rise due to factors such as NGO and government cooperation to create more innovative diagnostic methods, the rapid expansion of POC diagnosis methods, and low-cost therapies.

Global Adult Hemoglobinopathy Testing Market: Growth Factors

The adult hemoglobinopathy testing market is anticipated to rise over the forecast period owing to increasing incidences of sickle cell disease, thalassemia, and other hemoglobinopathies. The industry is also influenced by policymakers' increasing support for measuring and controlling diseases related to blood, as well as advances in technology. During the forecast period, the developing region is expected to provide growth opportunities for the industry. The global adult hemoglobinopathy testing market is expected to face some challenges that could limit its expansion. Adult hemoglobinopathy research market development is likely to be hampered by a lack of knowledge about hemoglobinopathy disorders and testing in various developing and underdeveloped emerging economies. The market's development may be hampered by a lack of innovative screening technology procedures such as genetic testing, the sophistication of hemoglobinopathy tests, and the disease's rising prevalence.

Global Adult Hemoglobinopathy Testing Market: COVID-19 Impact

COVID-19 began in December of 2019 in Wuhan, China, and has quickly spread around the world since then. Given the rapid spread of the pandemic and the shortage of research, proper treatment and management of Coronavirus (COVID-19) infection in patients affected by adult Hematological testing could be difficult, particularly in some countries. Various programs are putting forward attempts at this critical point to generate papers with indications for the health treatment of these patients. Adult hemoglobinopathy research firms should take care of this opportunity. COVID-19 has also unleashed a slew of new opportunities for several private firms to join the market in order to satisfy the significant challenge. Apart from that, a programme that calculates hemoglobinopathy testings automatically is gaining popularity as an alternative to traditional studies. In addition, owing to the widespread outbreak of coronavirus disease (COVID-19) and the absence of an appropriate vaccine or cure, Adult hemoglobinopathy testing research is being used to measure the effectiveness of existing medications as a potential treatment, which is boosting market development. The expansion of the Adult hemoglobinopathy testing research industry has been aided by the COVID-19 pandemic. It's used to find potential COVID-19 drug candidates and to assess the cell model using Adult hemoglobinopathy testing. As a result, demand for Adult hemoglobinopathy testing research is projected to increase in 2020, boosting market share.

Global Adult Hemoglobinopathy Testing Market: Segmentation

The global adult hemoglobinopathy testing market is bifurcated into its Variant Type, Test Type, distribution channel, and regions. Based on the variant type, the global market is divided into Variant A2, and Variant F. Based on Test Type, the market is bifurcated into HPLC test, mass spectrometry, and hemoglobin electrophoresis. Based on the End User, the market is segmented into reference laboratories, hospitals, and academic & medical institutes. Geographically, the global adult hemoglobinopathy testing market is diversified into North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America.

Global Adult Hemoglobinopathy Testing Market: Regional Analysis

The global adult hemoglobinopathy testing market is dominated by Europe, which is predicted to continue to do so over the forecast period. Because of the increasing prevalence of hemoglobinopathy in countries like India and China, Asia Pacific is projected to rise faster than the rest of the world during the forecast period. Sickle Cell Anemia is a global health problem that is most prevalent in African and Sub-Asian countries, according to the World Health Organization. A significant number of people from the affected areas are migrating to Europe and North America, resulting in an increase in the number of new cases of hemoglobinopathy disorders being diagnosed. The adult hemoglobinopathy testing market is expected to boom in northern and central Europe, especially Germany, as a result of increased migration. Similarly, as a result of increased migration from Asia, the number of hemoglobinopathy cases observed in North America has increased, fueling the hemoglobinopathy testing market over the projected era. In the face of rising hemoglobinopathy genotypes, policymakers have implemented a variety of public health initiatives, such as genetic testing, screening services, and counseling, which will continue to propel the global adult hemoglobinopathy testing market within the forecast period.

Global Adult Hemoglobinopathy Testing Market: Competitive Players

Some of the key players in the adult hemoglobinopathy testing market are Chromsystems Instruments & Chemicals GmbH, PerkinElmer Inc., CapitalBio Technology Inc., Bio-Rad Laboratories, Inc., BioMedomics, Inc., Streck, Inc., Thermo Fisher Scientific Inc., Trinity Biotech, Baxter, and Bluebird Bio among others. 

This report segments the adult hemoglobinopathy testing market as follows:

Global Adult Hemoglobinopathy Testing Market: By Variant Type Segmentation Analysis

  • Variant A2
  • Variant F

Global Adult Hemoglobinopathy Testing Market: By Test Type Segmentation Analysis

  • HPLC Test
  • Mass Spectrometry
  • Hemoglobin Electrophoresis

Global Adult Hemoglobinopathy Testing Market: By End User Segmentation Analysis

  • Hospitals
  • Reference Laboratories
  • Academic & Medical Institutes

Global Adult Hemoglobinopathy Testing Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Adult Hemoglobinopathy Testing
    2. 1.2. Global Adult Hemoglobinopathy Testing Market, 2020 & 2026 (USD Million)
    3. 1.3. Global Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    4. 1.4. Global Adult Hemoglobinopathy Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global Adult Hemoglobinopathy Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 Adult Hemoglobinopathy Testing Market – Variant Type Analysis
    1. 2.1. Global Adult Hemoglobinopathy Testing Market – Variant Type Overview
    2. 2.2. Global Adult Hemoglobinopathy Testing Market Share, by Variant Type, 2020 & 2026 (USD Million)
    3. 2.3. Variant A2
      1. 2.3.1. Global Variant A2 Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    4. 2.4. Variant F
      1. 2.4.1. Global Variant F Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Adult Hemoglobinopathy Testing Market – Test Type Analysis
    1. 3.1. Global Adult Hemoglobinopathy Testing Market – Test Type Overview
    2. 3.2. Global Adult Hemoglobinopathy Testing Market Share, by Test Type, 2020 & 2026 (USD Million)
    3. 3.3. HPLC Test
      1. 3.3.1. Global HPLC Test Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    4. 3.4. Mass Spectrometry
      1. 3.4.1. Global Mass Spectrometry Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    5. 3.5. Hemoglobin Electrophoresis
      1. 3.5.1. Global Hemoglobin Electrophoresis Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Adult Hemoglobinopathy Testing Market – End User Analysis
    1. 4.1. Global Adult Hemoglobinopathy Testing Market – End User Overview
    2. 4.2. Global Adult Hemoglobinopathy Testing Market Share, by End User, 2020 & 2026 (USD Million)
    3. 4.3. Hospitals
      1. 4.3.1. Global Hospitals Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    4. 4.4. Reference Laboratories
      1. 4.4.1. Global Reference Laboratories Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    5. 4.5. Academic & Medical Institutes
      1. 4.5.1. Global Academic & Medical Institutes Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
  5. Chapter 5 Adult Hemoglobinopathy Testing Market – Regional Analysis
    1. 5.1. Global Adult Hemoglobinopathy Testing Market Regional Overview
    2. 5.2. Global Adult Hemoglobinopathy Testing Market Share, by Region, 2020 & 2026 (USD Million)
    3. 5.3. North America
      1. 5.3.1. North America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
        1. 5.3.1.1. North America Adult Hemoglobinopathy Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 5.3.2. North America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026
        1. 5.3.2.1. North America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      3. 5.3.3. North America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026
        1. 5.3.3.1. North America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      4. 5.3.4. North America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026
        1. 5.3.4.1. North America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      5. 5.3.5. U.S.
        1. 5.3.5.1. U.S. Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      6. 5.3.6. Canada
        1. 5.3.6.1. Canada Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
        1. 5.4.1.1. Europe Adult Hemoglobinopathy Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 5.4.2. Europe Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026
        1. 5.4.2.1. Europe Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      3. 5.4.3. Europe Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026
        1. 5.4.3.1. Europe Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      4. 5.4.4. Europe Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026
        1. 5.4.4.1. Europe Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      5. 5.4.5. Germany
        1. 5.4.5.1. Germany Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      6. 5.4.6. France
        1. 5.4.6.1. France Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      7. 5.4.7. U.K.
        1. 5.4.7.1. U.K. Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      8. 5.4.8. Italy
        1. 5.4.8.1. Italy Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      9. 5.4.9. Spain
        1. 5.4.9.1. Spain Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      10. 5.4.10. Rest of Europe
        1. 5.4.10.1. Rest of Europe Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
        1. 5.5.1.1. Asia Pacific Adult Hemoglobinopathy Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 5.5.2. Asia Pacific Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026
        1. 5.5.2.1. Asia Pacific Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      3. 5.5.3. Asia Pacific Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026
        1. 5.5.3.1. Asia Pacific Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      4. 5.5.4. Asia Pacific Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026
        1. 5.5.4.1. Asia Pacific Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      5. 5.5.5. China
        1. 5.5.5.1. China Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      6. 5.5.6. Japan
        1. 5.5.6.1. Japan Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      7. 5.5.7. India
        1. 5.5.7.1. India Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      8. 5.5.8. South Korea
        1. 5.5.8.1. South Korea Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      9. 5.5.9. South-East Asia
        1. 5.5.9.1. South-East Asia Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      10. 5.5.10. Rest of Asia Pacific
        1. 5.5.10.1. Rest of Asia Pacific Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
        1. 5.6.1.1. Latin America Adult Hemoglobinopathy Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 5.6.2. Latin America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026
        1. 5.6.2.1. Latin America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      3. 5.6.3. Latin America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026
        1. 5.6.3.1. Latin America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      4. 5.6.4. Latin America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026
        1. 5.6.4.1. Latin America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      5. 5.6.5. Brazil
        1. 5.6.5.1. Brazil Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      6. 5.6.6. Mexico
        1. 5.6.6.1. Mexico Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      7. 5.6.7. Rest of Latin America
        1. 5.6.7.1. Rest of Latin America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
        1. 5.7.1.1. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 5.7.2. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026
        1. 5.7.2.1. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      3. 5.7.3. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026
        1. 5.7.3.1. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026
        1. 5.7.4.1. The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      5. 5.7.5. GCC Countries
        1. 5.7.5.1. GCC Countries Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      6. 5.7.6. South Africa
        1. 5.7.6.1. South Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      7. 5.7.7. Rest of Middle-East Africa
        1. 5.7.7.1. Rest of Middle-East Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
  6. Chapter 6 Adult Hemoglobinopathy Testing Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Developments
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. Bio-Rad Laboratories, Inc.
      1. 7.1.1. Company Overview
      2. 7.1.2. Product/Service Portfolio
      3. 7.1.3. Bio-Rad Laboratories, Inc. Sales, Revenue, and Gross Margin
      4. 7.1.4. Bio-Rad Laboratories, Inc. Revenue and Growth Rate
      5. 7.1.5. Bio-Rad Laboratories, Inc. Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. Thermo Fisher Scientific Inc.
      1. 7.2.1. Company Overview
      2. 7.2.2. Product/Service Portfolio
      3. 7.2.3. Thermo Fisher Scientific Inc. Sales, Revenue, and Gross Margin
      4. 7.2.4. Thermo Fisher Scientific Inc. Revenue and Growth Rate
      5. 7.2.5. Thermo Fisher Scientific Inc. Market Share
      6. 7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. PerkinElmer Inc.
      1. 7.3.1. Company Overview
      2. 7.3.2. Product/Service Portfolio
      3. 7.3.3. PerkinElmer Inc. Sales, Revenue, and Gross Margin
      4. 7.3.4. PerkinElmer Inc. Revenue and Growth Rate
      5. 7.3.5. PerkinElmer Inc. Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Chromsystems Instruments & Chemicals GmbH
      1. 7.4.1. Company Overview
      2. 7.4.2. Product/Service Portfolio
      3. 7.4.3. Chromsystems Instruments & Chemicals GmbH Sales, Revenue, and Gross Margin
      4. 7.4.4. Chromsystems Instruments & Chemicals GmbH Revenue and Growth Rate
      5. 7.4.5. Chromsystems Instruments & Chemicals GmbH Market Share
      6. 7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.5. BioMedomics, Inc
      1. 7.5.1. Company Overview
      2. 7.5.2. Product/Service Portfolio
      3. 7.5.3. BioMedomics, Inc Sales, Revenue, and Gross Margin
      4. 7.5.4. BioMedomics, Inc Revenue and Growth Rate
      5. 7.5.5. BioMedomics, Inc Market Share
      6. 7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 7.6. CapitalBio Technology Inc
      1. 7.6.1. Company Overview
      2. 7.6.2. Product/Service Portfolio
      3. 7.6.3. CapitalBio Technology Inc Sales, Revenue, and Gross Margin
      4. 7.6.4. CapitalBio Technology Inc Revenue and Growth Rate
      5. 7.6.5. CapitalBio Technology Inc Market Share
      6. 7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.7. Trinity Biotech
      1. 7.7.1. Company Overview
      2. 7.7.2. Product/Service Portfolio
      3. 7.7.3. Trinity Biotech Sales, Revenue, and Gross Margin
      4. 7.7.4. Trinity Biotech Revenue and Growth Rate
      5. 7.7.5. Trinity Biotech Market Share
      6. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.8. Streck, Inc
      1. 7.8.1. Company Overview
      2. 7.8.2. Product/Service Portfolio
      3. 7.8.3. Streck, Inc Sales, Revenue, and Gross Margin
      4. 7.8.4. Streck, Inc Revenue and Growth Rate
      5. 7.8.5. Streck, Inc Market Share
      6. 7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.9. Baxter
      1. 7.9.1. Company Overview
      2. 7.9.2. Product/Service Portfolio
      3. 7.9.3. Baxter Sales, Revenue, and Gross Margin
      4. 7.9.4. Baxter Revenue and Growth Rate
      5. 7.9.5. Baxter Market Share
      6. 7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.10. Bluebird Bio
      1. 7.10.1. Company Overview
      2. 7.10.2. Product/Service Portfolio
      3. 7.10.3. Bluebird Bio Sales, Revenue, and Gross Margin
      4. 7.10.4. Bluebird Bio Revenue and Growth Rate
      5. 7.10.5. Bluebird Bio Market Share
      6. 7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 Adult Hemoglobinopathy Testing — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. Adult Hemoglobinopathy Testing Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Key Mandates and Regulations
    4. 8.4. Technology Roadmap and Timeline
    5. 8.5. Adult Hemoglobinopathy Testing Market – Attractiveness Analysis
      1. 8.5.1. By Variant Type
      2. 8.5.2. By Test Type
      3. 8.5.3. By End User
      4. 8.5.4. By Region
  9. Chapter 9 Marketing Strategy Analysis
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trends
    5. 9.5. Economic/Political Environmental Change
  10. Chapter 10 Report Conclusion & Key Insights
    1. 10.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  11. Chapter 11 Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Statistical Models
        1. 11.3.3.1. Company Share Analysis Model
        2. 11.3.3.2. Revenue Based Modeling
      4. 11.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Adult Hemoglobinopathy Testing
      Fig.2	Global Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.3	Global Adult Hemoglobinopathy Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global Adult Hemoglobinopathy Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global Adult Hemoglobinopathy Testing Market Share, by Variant Type, 2020 & 2026 (USD Million)
      Fig.6	Global Variant A2 Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.7	Global Variant F Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.8	Global Adult Hemoglobinopathy Testing Market Share, by Test Type, 2020 & 2026 (USD Million)
      Fig.9	Global HPLC Test Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.10	Global Mass Spectrometry Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.11	Global Hemoglobin Electrophoresis Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.12	Global Adult Hemoglobinopathy Testing Market Share, by End User, 2020 & 2026 (USD Million)
      Fig.13	Global Hospitals Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.14	Global Reference Laboratories Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.15	Global Academic & Medical Institutes Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.16	Global Adult Hemoglobinopathy Testing Market Share, by Region, 2020 & 2026 (USD Million)
      Fig.17	North America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.18	U.S. Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.19	Canada Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.20	Europe Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.21	Germany Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.22	France Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.23	U.K. Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.24	Italy Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.25	Spain Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.26	Rest of Europe Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.27	Asia Pacific Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.28	China Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.29	Japan Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.30	India Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.31	South  Korea Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.32	South-East Asia Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.33	Rest of Asia Pacific Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.34	Latin America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.35	Brazil Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.36	Mexico Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.37	Rest of Latin America Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.38	The Middle-East and Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.39	GCC Countries Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.40	South Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.41	Rest of Middle-East Africa Adult Hemoglobinopathy Testing Market, 2016 – 2026 (USD Million)
      Fig.42	Competitor Market Share – Revenue
      Fig.43	Bio-Rad Laboratories, Inc. Revenue and Growth Rate
      Fig.44	Bio-Rad Laboratories, Inc. Market Share
      Fig.45	Thermo Fisher Scientific Inc. Revenue and Growth Rate
      Fig.46	Thermo Fisher Scientific Inc. Market Share
      Fig.47	PerkinElmer Inc. Revenue and Growth Rate
      Fig.48	PerkinElmer Inc. Market Share
      Fig.49	Chromsystems Instruments & Chemicals GmbH Revenue and Growth Rate
      Fig.50	Chromsystems Instruments & Chemicals GmbH Market Share
      Fig.51	BioMedomics, Inc Revenue and Growth Rate
      Fig.52	BioMedomics, Inc Market Share
      Fig.53	CapitalBio Technology Inc Revenue and Growth Rate
      Fig.54	CapitalBio Technology Inc Market Share
      Fig.55	Trinity Biotech Revenue and Growth Rate
      Fig.56	Trinity Biotech Market Share
      Fig.57	Streck, Inc Revenue and Growth Rate
      Fig.58	Streck, Inc Market Share
      Fig.59	Baxter Revenue and Growth Rate
      Fig.60	Baxter Market Share
      Fig.61	Bluebird Bio Revenue and Growth Rate
      Fig.62	Bluebird Bio Market Share
      Fig.63	Market Dynamics
      Fig.64	Key Mandates and Regulations
      Fig.65	Technology Roadmap and Timeline
      Fig.66	Market Attractiveness Analysis – By Variant Type
      Fig.67	Market Attractiveness Analysis – By Test Type
      Fig.68	Market Attractiveness Analysis – By End User
      Fig.69	Market Attractiveness Analysis – By Region
      Fig.70	Market Channels
      Fig.71	Marketing Channel Development Trend
      Fig.72	Growth in World Gross Product, 2008-2018
      

      List of Tables

      	
      Table 1	Global Adult Hemoglobinopathy Testing Market, 2020 & 2026 (USD Million)
      Table 2	Global Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 3	Global Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 4	Global Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 5	Global Adult Hemoglobinopathy Testing Market, by Region, 2016 – 2026 (USD Million)
      Table 6	North America Adult Hemoglobinopathy Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 7	North America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 8	North America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 9	North America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 10 Europe Adult Hemoglobinopathy Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 11 Europe Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 12 Europe Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 13 Europe Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 14 Asia Pacific Adult Hemoglobinopathy Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 15 Asia Pacific Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 16 Asia Pacific Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 18 Latin America Adult Hemoglobinopathy Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 19 Latin America Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 20 Latin America Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 21 Latin America Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 22 The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 23 The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Variant Type, 2016 – 2026 (USD Million)
      Table 24 The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by Test Type, 2016 – 2026 (USD Million)
      Table 25 The Middle-East and Africa Adult Hemoglobinopathy Testing Market, by End User, 2016 – 2026 (USD Million)
      Table 26 Global Adult Hemoglobinopathy Testing Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 27 Global Adult Hemoglobinopathy Testing Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 28 Acquisitions and Mergers
      Table 29 Market Drivers – Impact Analysis
      Table 30 Market Restraints
      Table 31 Market Opportunities
      

Industry Major Market Players

  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer Inc.
  • CapitalBio Technology Inc.
  • Bio-Rad Laboratories Inc.
  • BioMedomics Inc.
  • Streck Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech
  • Baxter
  • Bluebird Bio

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions